Cargando…
Hub Genes in Non-Small Cell Lung Cancer Regulatory Networks
There are currently no accurate biomarkers for optimal treatment selection in early-stage non-small cell lung cancer (NSCLC). Novel therapeutic targets are needed to improve NSCLC survival outcomes. This study systematically evaluated the association between genome-scale regulatory network centralit...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776006/ https://www.ncbi.nlm.nih.gov/pubmed/36551208 http://dx.doi.org/10.3390/biom12121782 |